Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical substanceL04AL02Rozanolixizumab
Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 4 medicines
United States
FDA · 4 medicines



